Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 361 entries
View as:

From Nature to Bedside- Algae Based Bio Compound for Prevention and Treatment of Inflammation, Pain and IBD

Phase: N/A Priority: Normal
NCT ID: NCT06042582 Org: User:
Start: 11/01/23 End: 05/01/26 Due: 05/01/27

INfectious DIsease REgistry BIObank

Phase: N/A Priority: Normal
NCT ID: NCT06418048 Org: User:
Start: 02/01/24 End: 07/31/44 Due: 07/31/45

European Venous Registry

Phase: N/A Priority: Normal
NCT ID: NCT06906250 Org: User:
Start: 06/01/25 End: 09/30/34 Due: 09/30/35

5 fr Ultrahypofractionated WBI and SIB for Breast Cancer With Unfavorable Characteristics

Phase: N/A Priority: Normal
NCT ID: NCT07020780 Org: User:
Start: 07/01/25 End: 06/30/35 Due: 06/30/36

Neuron-specific Humoral and Cellular Immune Correlates of Structural and Functional Brain Connectomics in Neuropsychiatric Lupus

Phase: N/A Priority: Normal
NCT ID: NCT05880121 Org: User:
Start: 04/30/23 End: 04/29/26 Due: 04/29/27

Monitored Antiretroviral Pause in Chronic HIV-Infected Subjects With Long-Lasting Suppressed Viremia

Phase: N/A Priority: Normal
NCT ID: NCT03198325 Org: User:
Start: 07/27/16 End: 04/30/18 Due: 04/30/19

Role of18F-FDG PET-CT for Assessing and Predicting Response to Daratumumab and for Prognosis With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06170151 Org: User:
Start: 05/24/21 End: 12/01/22 Due: 12/01/23

CT-based Myocardial Characterization (CTMyoC)

Phase: N/A Priority: Normal
NCT ID: NCT06029400 Org: User:
Start: 10/12/20 End: 10/12/32 Due: 10/12/33

H2O-F - A PROSPECTIVE, MULTI-COUNTRY, MULTI-CENTRE, MULTI-CONDITION FEASIBILITY STUDY EVALUATING THE ESTABLISHMENT OF THE NATIONAL HEALTH OUTCOMES OBSERVATORY (H2O) ECOSYSTEM

Phase: N/A Priority: Normal
NCT ID: NCT06833892 Org: User:
Start: 01/01/23 End: 09/30/26 Due: 09/30/27

Size Up Bicuspid with the LIra MEthod: the SUBLIME Study

Phase: N/A Priority: Normal
NCT ID: NCT06657911 Org: User:
Start: 12/21/24 End: 04/30/26 Due: 04/30/27

MULTICENTER ULNAR NERVE ULTRASONOGRAPHIC and NEUROPHYSIOLOGICAL STUDY: NORMATIVE DATA COLLECTION

Phase: N/A Priority: Normal
NCT ID: NCT06818162 Org: User:
Start: 03/31/25 End: 03/31/26 Due: 03/31/27

ERCP Biliary Cannulation Success Using ESGE Algorithm

Phase: N/A Priority: Normal
NCT ID: NCT06380543 Org: User:
Start: 12/12/19 End: 03/30/25 Due: 03/30/26

Screening for Hepatitis Virus B Protein X (HBx) in Colitis-associated Cancer (CAC)

Phase: N/A Priority: Normal
NCT ID: NCT06833021 Org: User:
Start: 04/01/25 End: 04/01/26 Due: 04/01/27

Intramyocardial Delivery of Autologous Bone Marrow

Phase: N/A Priority: Normal
NCT ID: NCT00820586 Org: User:
Start: 05/31/07 End: 12/31/18 Due: 12/31/19

Hemodynamic Changes Induced by Alveolar Recruitment Maneuver With Respect to Volemic State in Colon Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03468764 Org: User:
Start: 03/31/18 End: 04/30/19 Due: 04/30/20

Evaluation of the Diagnostic and Prognostic Role of PET (PET/CT and PET/MRI) in Neuroendocrin Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT06159920 Org: User:
Start: 10/27/21 End: 12/27/24 Due: 12/27/25

Study of Social Cognition Processes With Multimodal MRI on Healthy Adult Patients.

Phase: N/A Priority: Normal
NCT ID: NCT06164964 Org: User:
Start: 04/22/10 End: 10/28/10 Due: 10/28/11

Early Drain Removal Versus Standard Drain Management After Distal Pancreatectomy (Early-Dist)

Phase: N/A Priority: Normal
NCT ID: NCT04609137 Org: User:
Start: 10/13/20 End: 10/30/23 Due: 10/30/24

SARS-CoV-2, TESTOSTERONE AND MALE FRAGILITY

Phase: N/A Priority: Normal
NCT ID: NCT06177002 Org: User:
Start: 05/19/20 End: 05/18/25 Due: 05/18/26

Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01167738 Org: User:
Start: 07/31/10 End: 04/30/15 Due: 04/30/16

Retrospective Observational Study on the Risk in Developing Long-COVID Syndrome and in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation to Vitamin D3 Supplementation

Phase: N/A Priority: Normal
NCT ID: NCT06452082 Org: User:
Start: 03/20/24 End: 03/31/27 Due: 03/31/28

Monocentric Retrospective Observational Study for Validation of Meta-analysis of the Metatrascryptome and Transcriptome of Eosynophyl Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT06071585 Org: User:
Start: 11/01/23 End: 11/01/24 Due: 11/01/25

Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD)

Phase: N/A Priority: Normal
NCT ID: NCT01327222 Org: User:
Start: 02/28/11 End: 02/28/11 Due: 02/28/12

Immune Activation, Neural Plasticity and Depression

Phase: N/A Priority: Normal
NCT ID: NCT06306248 Org: User:
Start: 03/03/23 End: 05/09/25 Due: 05/09/26

Controlling the Mental Health for a Better Response to Treatment in Patients With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT06306261 Org: User:
Start: 03/15/24 End: 03/15/25 Due: 03/15/26